Dermata Therapeutics (Dermata Therapeutics) Current Accrued Expense : $0.32 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Dermata Therapeutics Current Accrued Expense?

Dermata Therapeutics's Current Accrued Expense for the quarter that ended in Mar. 2024 was $0.32 Mil.

Dermata Therapeutics's quarterly Current Accrued Expense declined from Sep. 2023 ($0.11 Mil) to Dec. 2023 ($0.04 Mil) but then increased from Dec. 2023 ($0.04 Mil) to Mar. 2024 ($0.32 Mil).

Dermata Therapeutics's annual Current Accrued Expense increased from Dec. 2021 ($0.24 Mil) to Dec. 2022 ($0.26 Mil) but then declined from Dec. 2022 ($0.26 Mil) to Dec. 2023 ($0.04 Mil).

Dermata Therapeutics Current Accrued Expense Historical Data

The historical data trend for Dermata Therapeutics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermata Therapeutics Current Accrued Expense Chart

Dermata Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

0.15

0.05

0.24

0.26

0.04

Dermata Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial													0.58	0.06	0.11	0.04	0.32

Dermata Therapeutics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Dermata Therapeutics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Dermata Therapeutics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Dermata Therapeutics (Dermata Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dermata Therapeutics Inc (NAS:DRMAW) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

DRMA:USA

Address

3525 Del Mar Heights Road, Suite No. 322, San Diego, CA, USA, 92130

Website

https://www.dermatarx.com

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.